SeaCrest Wealth Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $244K | Sell |
1,150
-518
| -31% | -$102K | 0.03% | 470 |
|
|
2026
Q1 | $327K | Sell |
1,668
-76
| -4% | -$14.8K | 0.04% | 449 |
|
|
2025
Q4 | $311K | Sell |
1,744
-403
| -19% | -$73.4K | 0.03% | 451 |
|
|
2025
Q3 | $388K | Buy |
2,147
+24
| +1% | +$4.26K | 0.04% | 385 |
|
|
2025
Q2 | $381K | Sell |
2,123
-9
| -0.4% | -$1.56K | 0.04% | 392 |
|
|
2025
Q1 | $361K | Buy |
2,132
+405
| +23% | +$66.5K | 0.04% | 423 |
|
|
2024
Q4 | $261K | Buy |
1,727
+12
| +0.7% | +$1.87K | 0.03% | 534 |
|
|
2024
Q3 | $266K | Sell |
1,715
-21
| -1% | -$3.14K | 0.03% | 527 |
|
|
2024
Q2 | $238K | Sell |
1,736
-9
| -0.5% | -$1.23K | 0.03% | 533 |
|
|
2024
Q1 | $232K | Sell |
1,745
-50
| -3% | -$6.49K | 0.03% | 525 |
|
|
2023
Q4 | $255K | Hold |
1,795
| – | – | 0.03% | 506 |
|
|
2023
Q3 | $219K | Sell |
1,795
-231
| -11% | -$30.8K | 0.03% | 537 |
|
|
2023
Q2 | $285K | Sell |
2,026
-17
| -0.8% | -$2.34K | 0.04% | 479 |
|
|
2023
Q1 | $289K | Sell |
2,043
-112
| -5% | -$16K | 0.04% | 472 |
|
|
2022
Q4 | $337K | Hold |
2,155
| – | – | 0.05% | 421 |
|
|
2022
Q3 | $264K | Sell |
2,155
-48
| -2% | -$6.32K | 0.04% | 464 |
|
|
2022
Q2 | $293K | Sell |
2,203
-3
| -0.1% | -$409 | 0.04% | 469 |
|
|
2022
Q1 | $302K | Sell |
2,206
-315
| -12% | -$43.9K | 0.03% | 502 |
|
|
2021
Q4 | $436K | Buy |
2,521
+68
| +3% | +$10.3K | 0.05% | 395 |
|
|
2021
Q3 | $356K | Buy |
2,453
+243
| +11% | +$35.6K | 0.04% | 442 |
|
|
2021
Q2 | $292K | Sell |
2,210
-107
| -5% | -$14K | 0.04% | 510 |
|
|
2021
Q1 | $297K | Sell |
2,317
-51
| -2% | -$6.28K | 0.04% | 478 |
|
|
2020
Q4 | $282K | Buy |
2,368
+146
| +7% | +$17.8K | 0.04% | 457 |
|
|
2020
Q3 | $254K | Sell |
2,222
-3,264
| -59% | -$386K | 0.04% | 448 |
|
|
2020
Q2 | $625K | Buy |
5,486
+160
| +3% | +$17K | 0.11% | 216 |
|
|
2020
Q1 | $428K | Buy |
5,326
+2,685
| +102% | +$278K | 0.09% | 235 |
|
|
2019
Q4 | $282K | Sell |
2,641
-264
| -9% | -$27.5K | 0.05% | 418 |
|
|
2019
Q3 | $311K | Buy |
2,905
+385
| +15% | +$39.5K | 0.06% | 384 |
|
|
2019
Q2 | $257K | Buy |
2,520
+108
| +4% | +$10.4K | 0.05% | 409 |
|
|
2019
Q1 | $217K | Buy |
2,412
+66
| +3% | +$5.72K | 0.04% | 440 |
|
|
2018
Q4 | $195K | Sell |
2,346
-807
| -26% | -$75.7K | 0.04% | 422 |
|
|
2018
Q3 | $340K | Hold |
3,153
| – | – | 0.06% | 360 |
|
|
2018
Q2 | $347K | Buy |
3,153
+9
| +0.3% | +$938 | 0.06% | 343 |
|
|
2018
Q1 | $315K | Sell |
3,144
-2
| -0.1% | -$205 | 0.06% | 357 |
|
|
2017
Q4 | $310K | Buy |
+3,146
| New | +$298K | 0.06% | 358 |
|
Other funds holding DGX
EIG
SeaCrest Wealth Management's DGX Position: Q2 2026 in Review
SeaCrest Wealth Management reduced its Quest Diagnostics (DGX) stake by 31% in Q2 2026, selling an estimated $102K and leaving 1,150 shares worth $244K. The position accounts for 0.03% of the portfolio, ranked #470.
SeaCrest Wealth Management first reported a position in DGX in Q4 2017 and has held it in 35 quarters since. The position peaked at $625K in Q2 2020. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- SeaCrest Wealth Management held 1,150 shares of Quest Diagnostics worth $244K as of Q2 2026.
- SeaCrest Wealth Management sold 518 Quest Diagnostics shares in Q2 2026, an estimated $102K.
- Quest Diagnostics made up 0.03% of SeaCrest Wealth Management's portfolio in Q2 2026, its #470 holding.
- SeaCrest Wealth Management first reported a position in Quest Diagnostics in Q4 2017 and has held it in 35 quarters since.
- SeaCrest Wealth Management's Quest Diagnostics position peaked at $625K in Q2 2020.
- 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on SeaCrest Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.